Melbourne-based biotechnology company Cartherics has raised $15 million to help advance its mission to rearm the body's ...

A much-anticipated new treatment for ovarian cancer discovered in Melbourne is also being explored for other conditions ...

Australian and Kiwi startups in fields as diverse as cell therapy, wastewater treatment, and local government software raised ...

The latest funding will support the first clinical trial for CTH-401, the startup’s lead cell therapy product, to treat ovarian cancer.

Cartherics Pty Ltd ("Cartherics" or "Company"), a biotechnology company developing immune cell therapies for the treatment of ...

Melbourne biotech company Cartherics will announce today that it has raised well over its target $15m from private investors to start clinical trials of its unique treatment in women with ovarian ...

Don't miss out on the headlines from Victoria. Followed categories will be added to My News. Melbourne biotech company Cartherics will announce today that it has raised well over its target $15m ...